GlassScriptPhysician profile
Brendan Barrett
NPI 1578903126
$2,646.14
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2021: $134 · 2022: $720 · 2023: $247 · 2024: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mvp Orthopedics INC | $607.00 | 2019 | |
| Arthrex, INC. | $306.36 | 2019 | |
| Organogenesis INC. | $225.14 | 2022-2024 | Cygnus Dual |
| Melinta Therapeutics, LLC | $210.49 | 2019-2022 | |
| Abbvie INC. | $195.83 | 2021-2024 | Dalvance |
| Wright Medical Technology, INC. | $175.56 | 2019 | |
| Horizon Therapeutics Plc | $167.30 | 2022-2023 | Krystexxa |
| Smith+Nephew, INC. | $93.72 | 2022-2024 | Renasys Go V2 Home, Grafix Pl |
| Nevro Corp. | $92.02 | 2021-2023 | Senza |
| Stryker Corporation | $77.80 | 2019-2023 | Inbone |
| Solventum Corporation | $64.51 | 2024 | Activ.A.C., Promogran Prisma, 3m Coban |
| Kci USA, INC. | $64.00 | 2021-2023 | Promogran Prisma, Kerramax Care, Activ.A.C. |
| Ani Pharmaceuticals, INC. | $56.27 | 2024 | Purified Cortrophin Gel |
| Grt US Holding, INC. | $53.21 | 2022 | |
| Kerecis Limited | $43.08 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $37.83 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Nabriva Therapeutics, Plc | $33.78 | 2022 | |
| Paratek Pharmaceuticals, INC. | $31.68 | 2022-2024 | Nuzyra |
| Integra Lifesciences Corporation | $19.01 | 2023 | Tenoglide |
| Paragon 28, INC. | $15.56 | 2021 | |
| Orthofix Medical, INC. | $14.01 | 2019 | |
| Heron Therapeutics, INC. | $13.48 | 2023 | Zynrelef |
| Medtronic, INC. | $13.18 | 2022 | |
| Checkpoint Surgical, INC | $12.98 | 2022 | |
| Anika Therapeutics, INC. | $12.77 | 2022 | |
| Cashflow Solutions, LLC | $9.57 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.